CV Sciences, Inc. (OTCMKTS:CVSI) Sees Significant Decrease in Short Interest

CV Sciences, Inc. (OTCMKTS:CVSI) saw a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 9,800 shares, a decrease of 54.8% from the October 15th total of 21,700 shares. Based on an average daily trading volume, of 550,900 shares, the short-interest ratio is currently 0.0 days.

CV Sciences Price Performance

OTCMKTS:CVSI remained flat at $0.05 on Wednesday. 215,303 shares of the company’s stock were exchanged, compared to its average volume of 279,435. CV Sciences has a twelve month low of $0.03 and a twelve month high of $0.10. The firm has a fifty day moving average of $0.05 and a 200 day moving average of $0.05. The stock has a market capitalization of $8.42 million, a price-to-earnings ratio of -4.56 and a beta of 0.59.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.